PAVmed (PAVM) Share-based Compensation (2016 - 2026)

PAVmed has reported Share-based Compensation for 11 years, with the latest figure at $917000.0 in Q2 2026.

• On a quarterly basis, Share-based Compensation fell 63.32% year-over-year to $917000.0 in Q2 2026; TTM through Jun 2026 was $2.5 million, a 1.52% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 73.53% from the prior year.
• Share-based Compensation was $917000.0 for Q2 2026 at PAVmed, up from $232000.0 in the prior quarter.
• The five-year high for Share-based Compensation was $18.1 million in Q1 2023, with the low at $232000.0 in Q4 2025.
• Average Share-based Compensation over 5 years is $6.6 million, with a median of $2.5 million recorded in 2025.
• The largest YoY upside for Share-based Compensation was 60.71% in 2022 against a maximum downside of 99.87% in 2022.
• Over 5 years, Share-based Compensation stood at $4.9 million in 2022, then sank by 60.23% to $2.0 million in 2023, then tumbled by 62.75% to $733000.0 in 2024, then slumped by 68.35% to $232000.0 in 2025, then jumped by 295.26% to $917000.0 in 2026.
• The last three Share-based Compensation figures came in at $917000.0 (Q2 2026), $232000.0 (Q4 2025), and $383000.0 (Q3 2025), per Business Quant data.